1. Home
  2. Analysis
  3. Ondansetron-hydrochloride
  4. Oxytocin

Ondansetron hydrochloride and Oxytocin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 16 people who take Ondansetron hydrochloride and Oxytocin. Common interactions include maternal exposure during pregnancy among females.

The phase IV clinical study analyzes what interactions people who take Ondansetron hydrochloride and Oxytocin have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 01, 2023

16 people who take Ondansetron hydrochloride and Oxytocin together, and have interactions are studied.

What is Ondansetron hydrochloride?

Ondansetron hydrochloride has active ingredients of ondansetron hydrochloride. It is used in nausea. Currently, eHealthMe is studying from 9,034 Ondansetron hydrochloride users.

What is Oxytocin?

Oxytocin has active ingredients of oxytocin. It is used in pain. Currently, eHealthMe is studying from 2,829 Oxytocin users.

Number of Ondansetron hydrochloride and Oxytocin reports submitted per year:

Ondansetron hydrochloride and Oxytocin drug interactions.

Common Ondansetron Hydrochloride and Oxytocin drug interactions by gender *:

female:

  1. Maternal exposure during pregnancy
  2. Hypoxia
  3. Drug ineffective
  4. Premature delivery
  5. Accelerated hypertension
  6. Angioedema
  7. Injection site erythema
  8. Pregnancy

male:

n/a

Common Ondansetron Hydrochloride and Oxytocin drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Drug ineffective
  2. Maternal exposure during pregnancy
  3. Premature delivery
  4. Angioedema

30-39:

  1. Hypoxia
  2. Maternal exposure during pregnancy
  3. Accelerated hypertension
  4. Injection site erythema
  5. Pregnancy

40-49:

n/a

50-59:

n/a

60+:

n/a

Common conditions people have *:

  1. Uterine Contractions During Pregnancy: 6 people, 37.50%
  2. Nausea And Vomiting: 4 people, 25.00%
  3. Type 1 Diabetes: 3 people, 18.75%
  4. Pulmonary Oedema (fluid accumulation in the lungs): 3 people, 18.75%
  5. Pulmonary Hypertension (increase in blood pressure in the lung artery): 3 people, 18.75%
  6. Pre-Eclampsia (high blood pressure and significant amounts of protein in the urine of a pregnant woman): 3 people, 18.75%
  7. Maternal Therapy To Enhance Foetal Lung Maturity: 3 people, 18.75%
  8. Hyperemesis Gravidarum (condition characterized by severe nausea, vomiting, weight loss, and electrolyte disturbance): 3 people, 18.75%
  9. High Blood Pressure: 3 people, 18.75%
  10. Uterine Atony (failure of the uterus to contract following delivery): 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Ondansetron hydrochloride and Oxytocin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drug side effects by duration, gender and age:

Common Ondansetron hydrochloride drug interactions:

Browse interactions between Ondansetron hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Oxytocin drug interactions:

Browse interactions between Oxytocin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ondansetron hydrochloride and oxytocin (the active ingredients of Ondansetron hydrochloride and Oxytocin, respectively), and Ondansetron hydrochloride and Oxytocin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Ondansetron hydrochloride and Oxytocin.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.